WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 6 fonti

New experimental Alzheimer's drug shows potential after study shows slower cognitive decline | Fortune

A study on Biogen's diranersen found it slowed cognitive decline and has promise in treating Alzheimer's disease, researchers found.

Raccontata daapnews.comabcnews.comthestar.comindependent.co.ukmedpagetoday.comfortune.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
fortune.comStai leggendo1 g fa

New experimental Alzheimer's drug shows potential after study shows slower cognitive decline | Fortune

A study on Biogen's diranersen found it slowed cognitive decline and has promise in treating Alzheimer's disease, researchers found.

originale
independent.co.uk1 g fa

New experimental drug shows promise in slowing early Alzheimer’s

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau

Leggi questa versione → originale
apnews.com1 g fa

An experimental Alzheimer's drug shows some promise as researchers hunt new approaches

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

Leggi questa versione → originale
thestar.com1 g fa

An experimental Alzheimer’s drug shows some promise as researchers hunt new approaches

WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau,

Leggi questa versione → originale
abcnews.com1 g fa

Experimental Alzheimer's drug shows some promise as researchers hunt new approaches

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau

Leggi questa versione → originale
medpagetoday.com1 g fa

Novel Alzheimer's Drug Targeting Tau Shows Promise in Mid-Stage Trial

Diranersen misses study's main goal but shows signs of cognitive benefit

Leggi questa versione → originale

Timeline cronologica

  1. martedì 14 luglio 2026·apnews.com

    An experimental Alzheimer's drug shows some promise as researchers hunt new approaches

    An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

  2. martedì 14 luglio 2026·abcnews.com

    Experimental Alzheimer's drug shows some promise as researchers hunt new approaches

    An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau

  3. martedì 14 luglio 2026·thestar.com

    An experimental Alzheimer’s drug shows some promise as researchers hunt new approaches

    WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called…

  4. martedì 14 luglio 2026·independent.co.uk

    New experimental drug shows promise in slowing early Alzheimer’s

    An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau

  5. martedì 14 luglio 2026·medpagetoday.com

    Novel Alzheimer's Drug Targeting Tau Shows Promise in Mid-Stage Trial

    Diranersen misses study's main goal but shows signs of cognitive benefit

  6. martedì 14 luglio 2026·fortune.com

    New experimental Alzheimer's drug shows potential after study shows slower cognitive decline | Fortune

    A study on Biogen's diranersen found it slowed cognitive decline and has promise in treating Alzheimer's disease, researchers found.